Roles of Coagulation and Fibrinolysis in Angiotensin II-Enhanced Microvascular Thrombosis

Microcirculation

Volumn 21, Issue 5, 2014, Pages 401-407

  Senchenkova, Elena Y ^a,b   Russell, Janice ^a   Esmon, Charles T ^c   Granger, D Neil ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Angiotensin II; Anticoagulants; Coagulation; Fibrinolysis; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; ANGIOTENSIN II; ANTICOAGULANT AGENT; ANTITHROMBIN III; ENDOTHELIAL PROTEIN C RECEPTOR; FIBRINOLYTIC AGENT; HEPARIN; HIRUDIN; THROMBOPLASTIN; ANTITHROMBIN; HEMOSTATIC AGENT; PROTEASE NEXIN I; PROTEIN C; SERPINE2 PROTEIN, MOUSE; THROMBIN; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD CLOTTING; BLOOD FLOW; BLOOD PRESSURE; COMPARATIVE STUDY; CONTROLLED STUDY; CREMASTER MUSCLE; ENDOTHELIUM CELL; FIBRINOLYSIS; HYPERTENSION; MALE; MICROVASCULAR THROMBOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBIN TIME; THROMBOSIS; ANIMAL; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MICROVASCULATURE; PATHOLOGY;

ANGIOTENSIN II; ANIMALS; ANTITHROMBIN III; ANTITHROMBINS; FIBRINOLYSIS; HEMOSTATICS; MALE; MICE; MICE, KNOCKOUT; MICROVESSELS; PROTEIN C; SERPIN E2; THROMBIN; THROMBOPLASTIN; THROMBOSIS; VASOCONSTRICTOR AGENTS;

EID: 84904254705     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/micc.12120     Document Type: Article

References (45)

1. Brown NJ, Vaughan DE. Prothrombotic effects of angiotensin. Adv Intern Med 45: 419-429, 2000.
2. Celi A, Cianchetti S, Dell'Omo G, Pedrinelli R. Angiotensin II, tissue factor and the thrombotic paradox of hypertension. Expert Rev Cardiovasc Ther 8: 1723-1729, 2010.
3. Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation 118: 2286-2297, 2008.
4. Doller A, Gauer S, Sobkowiak E, Geiger H, Pfeilschifter J, Eberhardt W. Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen R. Am J Pathol 174: 1252-1263, 2009.
5. Ekholm M, Wallen NH, Johnsson H, Eliasson K, Kahan T. Long-term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertension. Clin Sci (Lond) 103: 151-155, 2002.
6. Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 29(7 Suppl.): S48-S51; discussion -2, 2001.
7. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345: 408-416, 2001.
8. He M, He X, Xie Q, Chen F, He S. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes. Thromb Res 117: 579-590, 2006.
9. High KA. Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins. Arch Pathol Lab Med 112: 28-36, 1988.
10. Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD. Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway. Am J Physiol Cell Physiol 279: C98-C107, 2000.
11. Ishikawa M, Sekizuka E, Yamaguchi N, Nakadate H, Terao S, Granger DN, Minamitani H. Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature. Am J Physiol Heart Circ Physiol 292: H2306-H2315, 2007.
12. Izuhara Y, Takahashi S, Nangaku M, Takizawa S, Ishida H, Kurokawa K, van Ypersele de Strihou C, Hirayama N, Miyata T. Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis. Arterioscler Thromb Vasc Biol 28: 672-677, 2008.
13. Kaminska M, Mogielnicki A, Stankiewicz A, Kramkowski K, Domaniewski T, Buczko W, Chabielska E. Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats. J Physiol Pharmacol 56: 571-585, 2005.
14. Kerins DM, Hao Q, Vaughan DE. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 96: 2515-2520, 1995.
15. Kirchhofer D, Moran P, Bullens S, Peale F, Bunting S. A monoclonal antibody that inhibits mouse tissue factor function. J Thromb Haemost 3: 1098-1099, 2005.
16. Larsson PT, Schwieler JH, Wallen NH. Platelet activation during angiotensin II infusion in healthy volunteers. Blood Coagul Fibrinolysis 11: 61-69, 2000.
17. Li JS, Touyz RM, Schiffrin EL. Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats. Hypertension 31: 487-492, 1998.
18. Li W, Zheng X, Gu J, Hunter J, Ferrell GL, Lupu F, Esmon NL, Esmon CT. Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J Thromb Haemost 3: 1351-1359, 2005.
19. Lip GY. Hypertension and the prothrombotic state. J Hum Hypertens 14: 687-690, 2000.
20. Matsumoto T, Horie M. Angiotensin-converting enzyme inhibition and fibrinolytic balance. Hypertens Res 34: 448-449, 2011.
21. Mogielnicki A, Chabielska E, Pawlak R, Szemraj J, Buczko W. Angiotensin II enhances thrombosis development in renovascular hypertensive rats. Thromb Haemost 93: 1069-1076, 2005.
22. Monton M, Jimenez A, Nunez A, Lopez-Blaya A, Farre J, Gomez J, Zalba LR, Sánchez de Miguel L, Casado S, López-Farré A. Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation. J Cardiovasc Pharmacol 35: 906-913, 2000.
23. Müller DN, Mervaala EM, Dechend R, Fiebeler A, Park JK, Schmidt F, Theuer J, Breu V, Mackman N, Luther T, Schneider W, Gulba D, Ganten D, Haller H, Luft FC. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. Am J Pathol 157: 111-2225, 2000.
24. Nadar S, Lip GY. The prothrombotic state in hypertension and the effects of antihypertensive treatment. Curr Pharm 9: 1715-1732, 2003.
25. Nagai M, Yilmaz CE, Kirchhofer D, Esmon CT, Mackman N, Granger DN. Role of coagulation factors in cerebral venous sinus and cerebral microvascular thrombosis. Neurosurgery 66: 560-565; discussion 5-6, 2010.
26. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163: 740-745, 1986.
27. Nishimura H, Tsuji H, Masuda H, Nakagawa K, Nakahara Y, Kitamura H, Kasahara T, Sugano T, Yoshizumi M, Sawada S, Nakagawa M. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemost 77: 1189-1195, 1997.
28. Numaguchi Y, Ishii M, Kubota R, Morita Y, Yamamoto K, Matsushita T, Okumura K, Murohara T. Ablation of angiotensin IV receptor attenuates hypofibrinolysis via PAI-1 downregulation and reduces occlusive arterial thrombosis. Arterioscler Thromb Vasc Biol 29: 2102-2108, 2009.
29. Oelschlager C, Romisch J, Staubitz A, Stauss H, Leithauser B, Tillmanns H, Hölschermann H. Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells. Blood 99: 4015-4020, 2002.
30. Owens AP, III, Mackman N. Tissue factor and thrombosis: The clot starts here. Thromb Haemost 104: 432-439, 2010.
31. Remkova A, Remko M. The role of renin-angiotensin system in prothrombotic state in essential hypertension. Physiol Res 59: 13-23, 2010.
32. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 87: 1969-1973, 1993.
33. Rosenberg RD. Actions and interactions of antithrombin and heparin. N Engl J Med 292: 146-151, 1975.
34. Rupin A, Martin F, Vallez MO, Bonhomme E, Verbeuren TJ. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles. Thromb Haemost 86: 1528-1531, 2001.
35. Sawada K, Naiki M, Yago H, Matsushita K, Ohtsuki T, Kitagawa K, Matsumoto M, Hori M. Hypertension associated with reduced plasma thrombomodulin levels and a hypercoagulable state in rats. Clin Exp Hypertens 25: 73-84, 2003.
36. Senchenkova EY, Russell J, Almeida-Paula LD, Harding JW, Granger DN. Angiotensin II-mediated microvascular thrombosis. Hypertension 56: 1089-1095, 2010.
37. Senchenkova EY, Russell J, Kurmaeva E, Ostanin D, Granger DN. Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis. Hypertension 58: 959-965, 2011.
38. Sorg H, Hoffmann JN, Menger MD, Lindenblatt N, Goehring P, Vollmar B. Antithrombin is as effective as heparin and hirudin to prevent formation of microvascular thrombosis in a murine model. Thromb Haemost 96: 371-377, 2006.
39. Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113: 722-731, 2006.
40. Stokes KY, Clanton EC, Russell JM, Ross CR, Granger DN. NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circ Res 88: 499-505, 2001.
41. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J Clin Invest 95: 995-1001, 1995.
42. Vital SA, Terao S, Nagai M, Granger DN. Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension. Microcirculation 17: 641-649, 2010.
43. Wolberg AS. Thrombin generation assays: understanding how the method influences the results. Thromb Res 119: 663-665, 2007.
44. Yoshida H, Russell J, Granger DN. Thrombin mediates the extraintestinal thrombosis associated with experimental colitis. Am J Physiol Gastrointest Liver Physiol 295: G904-G908, 2008.
45. Yoshida H, Russell J, Stokes KY, Yilmaz CE, Esmon CT, Granger DN. Role of the protein C pathway in the extraintestinal thrombosis associated with murine colitis. Gastroenterology 135: 882-888, 2008.